Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinyi Duan

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Multiple Sclerosis and Related Disorders|November 15, 2025
Effectiveness and safety of ofatumumab in treatment-naive and oral DMT-switched multiple sclerosis patients: a multicenter observational study in ChinaYang Yang, Xinyi Duan, Jing Wang, et al.
Nature Chemistry|March 22, 2025
Light-driven propane dehydrogenation by a single-atom catalyst under near-ambient conditionsLeilei Kang, Beien Zhu, Qingqing Gu, et al.
Frontiers in Cellular and Infection Microbiology|November 15, 2023
Comparative analysis of clinical and immunological profiles across Omicron BA.5.2 subvariants using next-generation sequencing in a Chinese cohortJianliang Huang, Mingkai Xia, Rangjiao Liu, et al.
Journal of Integrative Plant Biology|November 22, 2024
The ABC transporter SmABCG1 mediates tanshinones export from the peridermic cells of Salvia miltiorrhiza rootYajing Li, Junfeng Chen, Jingyu Zhi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 27, 2026
Real-World Multicenter Cohort Study of Inebilizumab vs Low-Dose Rituximab in Neuromyelitis Optica Spectrum DisordersQiao Xu, Linming Zhang, Xinyi Duan, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Multiple Sclerosis and Related Disorders|November 15, 2025
Effectiveness and safety of ofatumumab in treatment-naive and oral DMT-switched multiple sclerosis patients: a multicenter observational study in ChinaYang Yang, Xinyi Duan, Jing Wang, et al.
Nature Chemistry|March 22, 2025
Light-driven propane dehydrogenation by a single-atom catalyst under near-ambient conditionsLeilei Kang, Beien Zhu, Qingqing Gu, et al.
Frontiers in Cellular and Infection Microbiology|November 15, 2023
Comparative analysis of clinical and immunological profiles across Omicron BA.5.2 subvariants using next-generation sequencing in a Chinese cohortJianliang Huang, Mingkai Xia, Rangjiao Liu, et al.
Journal of Integrative Plant Biology|November 22, 2024
The ABC transporter SmABCG1 mediates tanshinones export from the peridermic cells of Salvia miltiorrhiza rootYajing Li, Junfeng Chen, Jingyu Zhi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 27, 2026
Real-World Multicenter Cohort Study of Inebilizumab vs Low-Dose Rituximab in Neuromyelitis Optica Spectrum DisordersQiao Xu, Linming Zhang, Xinyi Duan, et al.
Pageof 4